| ID | Name | CAS | Properties |
MW (g/mol) |
| 24-049-1 |
5-«alpha»-Pregnan-3-«alpha»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 553.05 |
| 24-117-5 |
7«alpha»,12«alpha»-dihydroxy-3-oxy-4-chol-24-oate, TMS
|
|
2 | 693.26 |
| 24-159-9 |
16«alpha», 17-H2-OH GA53, methyl ester TMS ether
|
|
2 | 538.86 |
| 24-208-4 |
4-(2-Hydroxyethyl)-2,2-dimethyl-1,3-dioxolane, benzyldimethylsilyl ether
|
|
2 | 294.46 |
| 24-252-5 |
2-Naphthanilide, 2'-chloro-4-[4-diethylamino-o-tolylimino]-1,4-dihydro-1-oxo-
|
115604-50-7 |
2 | 471.98 |
| 24-329-0 |
3-(tert-Butyldimethylsilyloxy)-1-phenyl-4,5-dihydro-1H-pyrazole
|
|
2 | 276.45 |
| 24-409-1 |
17«alpha»-hydroxy-5«alpha»-androstan-3-one (2-enol), per-TMS
|
|
2 | 434.80 |
| 24-724-1 |
Oxadiazole, 1,2,4-, 5-(dichloromethyl)-3-(5-nitrofuran-2-yl)-
|
5671-14-7 |
2 | 264.02 |
| 24-864-6 |
5-«alpha»-Pregnan-3-«alpha»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 25-046-3 |
tert-Butyl-[2-[2-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 510.86 |
| 25-099-5 |
5-«alpha»-Pregnan-11-«beta»,20-«beta»-diol-3-one, MO-TMS
|
|
2 | 507.90 |
| 25-154-3 |
5«beta»-Pregnan-3«alpha»,20«beta»-diol, allyl-DMS
|
|
2 | 502.92 |
| 25-160-6 |
3«alpha»,11«beta»-dihydroxy-5«beta»-androstan-17-one, MO-TMS
|
|
2 | 538.00 |
| 25-174-1 |
1H-[1,2,3]triazole-4-carboxamide, 5-amino-1-(phenylmethyl)-
|
|
2 | 217.23 |
| 25-250-6 |
2,4,6,8-tetramethyl-2,4,6,8-tetra(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 452.76 |
| 25-266-9 |
5«alpha»-androst-1-en-1-methyl-17«beta»-oI-3-one, TMS
|
|
2 | 446.81 |
| 25-402-7 |
N-(2-Furylmethyl)-9(H)-trimethylsilyl-purin-6-(N-trimethylsilyl)amine
|
|
2 | 359.58 |
| 25-410-8 |
9H-imidazo[2,1-i]purine, 9-ethyl-7,8-dihydro-
|
93227-13-5 |
2 | 189.22 |
| 25-512-5 |
17-«beta»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, per-TMS
|
|
2 | 462.86 |
| 25-783-5 |
2-(N,n-di-n-butylamino)-3-(n-pentyl)pyrazine
|
|
2 | 277.46 |
| 25-827-6 |
3,16,17-Trihydroxy-5-abdrosten-11-one, tris-TMS
|
|
2 | 536.97 |
| 25-833-9 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,17«alpha»,25-triol, DMESI
|
|
2 | 707.34 |
| 26-016-5 |
(3S,4S)-3-tert-Butyldimethylsilyloxy-1-tert-butoxycarbonyl-4-hydroxyazepane
|
|
2 | 345.55 |
| 26-048-0 |
2-(2,2-Dimethylpentoxy)-3,6-di-(n-heptyl) pyrazine
|
116403-03-3 |
2 | 390.65 |
| 26-131-7 |
4,4'-Bis(4-amino-1-naphthylazo)-2,2'-stilbenedisulfonic acid
|
5463-64-9 |
2 | 678.74 |
| 26-154-2 |
Arabinaric acid, 2,3,4-tris-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
38165-95-6 |
2 | 541.02 |
| 26-165-0 |
5-Pregnane-11-one-3.alpha.,20.alpha.-diol, TMSO-TMS
|
|
2 | 566.06 |
| 26-324-3 |
5«beta»-pregn-8-ene-3«alpha»,17«alpha»,20«alpha»-triol
|
|
2 | 551.04 |
| 26-356-8 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)nonyloxy-
|
|
2 | 506.60 |
| 26-412-5 |
Pregnan-11-one, 3,17,20,21-tetrakis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,20S)-
|
56196-46-4 |
2 | 655.22 |
| 26-474-7 |
Cholanic acid, 3«alpha»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
2 | 639.14 |
| 26-480-0 |
3«alpha»,7«beta»,12«beta»-Trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 639.14 |
| 26-494-5 |
bis(1,3-dichloro-2-propyl)(2,3-dichloro-1-propyl)phosphate
|
|
2 | 430.91 |
| 26-539-5 |
(E)-10-Dodecenoic acid, 9-hydroxy-12-oxo, methyl ester, PFB-oxime, OH-TMS, # 1
|
|
2 | 509.59 |
| 26-667-3 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TBDMS-16,17-HFB
|
|
2 | 824.71 |
| 26-682-6 |
5«beta»-Cholestane-3«alpha»,7«alpha»,12«alpha»,24R,25-pentol, TMS
|
|
2 | 799.55 |
| 26-731-1 |
1, 1'-Thiobis(2-methyl-4-tert-butyldimethylsilyloxy-5-tert-butylbenzene)
|
|
2 | 587.06 |
| 26-804-0 |
12-Oxa-9-dodecenoic acid, 11-hydroxy, PFBO, TMS, methyl ester
|
|
2 | 509.58 |
| 26-833-8 |
2-Amino-6-methyl-4-oxo-1,3,3a,7-tetrazaindene
|
|
2 | 165.16 |
| 26-838-3 |
S-triazolo(2,3-a)pyrimidin-7-ol, 2-trifluoromethyl-5-methyl-
|
116529-17-0 |
2 | 218.14 |
| 26-996-8 |
3,4-Dihydro-3-phenyl-6-(1,1,3,3-tetramethylbutyl)-2h-1,3-benzoxazine
|
|
2 | 323.48 |
| 27-029-0 |
Oxadiazole, 1,2,4-, 3-chloromethyl-5-(5-nitrofuran-2-yl)-
|
|
2 | 229.58 |
| 27-209-0 |
2-(1-Naphthyl-N-trimethylsilyl-carbamoyl)benzoic acid, trimethylsilyl ester
|
|
2 | 435.67 |
| 27-243-2 |
5-«alpha»-Pregnan-3-«alpha»-16-«alpha»,20-«alpha»-triol, TMS
|
|
2 | 553.05 |
| 27-296-4 |
3«alpha»,7«alpha»,12«alpha»-Trihydroxy-5«beta»-cholestanoic acid, MeTMS
|
|
2 | 725.35 |
| 27-313-4 |
5«alpha»-Androstan-3«beta»,17«beta»-diol, allyl-DMS
|
|
2 | 488.89 |
| 27-357-6 |
2H-1,3-Benzoxazine, 6-(1,1-dimethylethyl)-3,4-dihydro-3-phenyl-
|
|
2 | 267.37 |
| 27-460-1 |
3«alpha»,17«beta»-Dihydroxy-5«alpha»-androstan-6-one, TMS
|
|
2 | 450.80 |
| 27-544-8 |
2-«alpha»-Hydroxy-9,15-cyclo-GA9, methyl ester [D2], TMS
|
|
2 | 416.58 |
| 27-584-4 |
L-Ornithine, N2,N5-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 474.94 |
| 27-593-4 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)octyloxy-
|
|
2 | 492.58 |
| 27-609-6 |
5«alpha»-Pregnane-3«alpha», 17«alpha», 20«beta»-triol, MO TMS
|
|
2 | 553.05 |
| 27-939-0 |
1,2,4-Triazin-5(2h)-one, 6-(1,1-dimethylethyl)-3-(methylthio)-
|
|
2 | 199.28 |
| 27-979-6 |
Oxadiazole, 1,2,4-, 5-(alpha-bromopropyl)-3-(5-nitrofuran-2-yl)-
|
|
2 | 302.08 |
| 28-062-2 |
3-Anilino-1,4-diphenyl-5-phenylimino-1,2,4-triazoline
|
|
2 | 403.49 |
| 28-093-8 |
3,4-Dihydroxyhydrocinnamic acid, O,O-bis-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 524.96 |
| 28-164-9 |
5-«alpha»-Pregnan-20-«alpha»-ol-3,11-dione, MO-TMS
|
|
2 | 462.74 |
| 28-410-5 |
Androst-1,4-dien-17«beta»-methyl-17«alpha»-ol-3-one, TMS
|
|
2 | 444.80 |
| 28-484-4 |
3H-v-triazolo[4,5-d]pyrimidine, 5-amino-3-ethyl-7-hydroxy-
|
|
2 | 180.17 |
| 28-500-5 |
2,6,10,10-Tetramethyl- 1-oxaspiro[ 4.5]dec-6-ene-2,8-diol, TMS
|
|
2 | 370.67 |
| 28-630-1 |
6«alpha»-Hydroxy-4-Chloro-1,2,dehydro-17«alpha»-methyltestosterone, bis-TMS
|
|
2 | 495.24 |
| 28-814-7 |
Urea, 1-(2-chloroethyl)-1-nitroso-3-(tetrahydro-4-thiopyranyl)-, s,s-dioxide
|
|
2 | 283.74 |
| 28-850-7 |
Phosphoramidic acid, (1-methylethyl)-, ethyl 3-methyl-4-(methylsulfonyl)phenyl ester
|
31972-44-8 |
2 | 335.36 |
| 28-913-7 |
1,3-Dihydrobenzimidazol-2-one, N,N'-bIis(tert-butyldimethylsilyl)-
|
|
2 | 362.67 |
| 29-037-9 |
2,2,4,4-Tetramethyl-1,3-cyclobutane-1,3-diol, trans, mono-TBDMS
|
|
2 | 258.47 |
| 29-052-2 |
5.xi.-Pregnan-11-one, 1.xi.,3.xi.,20.xi.-trihydroxy, MO-TMS
|
|
2 | 596.09 |
| 29-132-3 |
Pentaric acid, 2,3-dideoxy-4-O-(trimethylsilyl)-3-[[(trimethylsilyl)oxy]carbonyl]-, bis(trimethylsilyl) ester
|
|
2 | 480.85 |
| 29-172-9 |
Glycine, N-(3-methyl-1-oxo-2-butenyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55649-86-0 |
2 | 301.53 |
| 29-204-3 |
4-Pregnen-3-.beta.-ol-11,20-dione, MO-TMS
|
|
2 | 460.73 |
| 29-212-4 |
Propanoic acid, 2-hydroxy-2-methyl-3-(4-hydroxy-3-methoxyphenyl), tris-TMS
|
|
2 | 442.77 |
| 29-267-4 |
9H-Purin-2-amine, N-(trimethylsilyl)-6-[(trimethylsilyl)oxy]-9-[2,3,5-tris-O-(trimethylsilyl)-«beta»-D-ribofuranosyl]-
|
53294-38-5 |
2 | 644.15 |
| 29-413-1 |
3-Methyl-2,8,9-trioxa-5-azonia-1-boratatricyclo[3.3.3.0(1,5)]undecane
|
27664-61-5 |
2 | 171.00 |
| 29-470-8 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«beta»-diol, bisTMS
|
|
2 | 448.83 |
| 29-565-3 |
2-Quinolinecarboxylic acid, 4,8-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
|
2 | 421.72 |
| 29-592-3 |
3«alpha»,11«beta»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS
|
|
2 | 538.00 |
| 29-685-0 |
2,2,4,4,6,6,8,8,10-nonamethyl-10-(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 409.81 |
| 29-695-9 |
N6-TMS-2'-Deoxyadenosine, 3'-O-acetyl, 5'-O-TBDMS
|
|
2 | 479.72 |
| 29-763-3 |
Urea, 1,1'-(2,3,5,6-tetramethyl-p-phenylene)bis[3-(2-chloroethyl)-3-nitroso]-
|
|
2 | 433.30 |
| 29-800-1 |
5«beta»-Pregnan-3«alpha»,17«alpha»,20«beta»-triol, 3-(acetoxydimethyl)silyl-17,20-dimethylsilylene
|
|
2 | 494.81 |
| 29-851-5 |
3«beta»,17«beta»-Dihydroxy-5«alpha»-androstan-7-one, TMS
|
|
2 | 450.80 |
| 29-967-7 |
24-Nor-5«beta»-cholestane-3«alpha»,7«alpha»,12«alpha»,25-tetrol, TMS
|
|
2 | 711.37 |
| 30-022-3 |
5-«beta»-Pregnan-3-«alpha»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 553.05 |
| 30-070-0 |
5-«beta»-Pregnan-3-«alpha»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 553.05 |
| 30-075-5 |
5«beta»-Pregnane-3«alpha»,11«beta»,20«alpha»,21-tetrol, EO-TMS
|
|
2 | 627.21 |
| 30-076-4 |
5.alpha.-Pregnane-3.alpha.,11.beta.,20.alpha.,21-tetrol, EO-TMS
|
|
2 | 627.22 |
| 30-096-2 |
5-«alpha»-Pregnan-3-«alpha»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 553.05 |
| 30-117-8 |
7.alpha.-hydroxy-3-oxo-4-chol-24-oate, TMS
|
|
2 | 605.10 |
| 30-167-3 |
5«beta»-Cholestane-3«alpha»,7«alpha»,24S,25-tetrol, TMS
|
|
2 | 711.37 |
| 30-226-7 |
L-Threonine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107715-94-6 |
2 | 461.90 |
| 30-316-7 |
3«alpha»-Hydroxy-«DELTA»6-5«beta»-cholanoic acid, MeTMS
|
|
2 | 460.76 |
| 30-358-1 |
(3S,4R)-4-Azido-3-tert-butyldimethylsilyloxy-1-tert-butoxycarbonylazepane
|
|
2 | 370.56 |
| 30-368-0 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 3
|
|
2 | 729.28 |
| 30-369-9 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 2
|
|
2 | 729.27 |
| 30-453-5 |
Mannonic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-28-1 |
2 | 466.86 |
| 30-484-1 |
3«alpha»,7«beta»,14«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 697.30 |
| 30-555-2 |
(1H)-1,2,4-triazole-3-amino, 5-imino-1-(pyridin-2-yl)-
|
|
2 | 176.18 |
| 30-706-4 |
4-O-«beta»-Galactopyranosyl-D-mannopyranose, octakis(trimethylsilyl) ether (isomer 2)
|
|
2 | 919.75 |
| 30-807-2 |
GA7 di-acid 9,10-ene, methyl ester TMS ether
|
|
2 | 400.58 |
| 30-831-5 |
4-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TES
|
|
2 | 602.95 |
| 30-839-7 |
Sorbopyranose, 1,2,3,4,5-pentakis-O-(trimethylsilyl)-, L-
|
30645-02-4 |
2 | 541.06 |
|
« Previous Results
Next Results »
|